Overview

Plasma Volume Replacement (PVR) Therapy With Colloid and Crystalloid Solutions

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy of target controlled fluid therapy with a hyper-oncotic balanced HES solution compared to an iso-oncotic HES solution in patients undergoing elective surgery of the pancreatic head. A third group receiving a balanced electrolyte solution (without colloidal volume replacement) will serve as a control for descriptive analysis.
Phase:
Phase 4
Details
Lead Sponsor:
B. Braun Melsungen AG
Treatments:
Pharmaceutical Solutions